{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:52:57Z","timestamp":1790700777836,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ijrobp.2015.02.021","type":"journal-article","created":{"date-parts":[[2015,6,3]],"date-time":"2015-06-03T02:04:55Z","timestamp":1433297095000},"page":"555-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting"],"prefix":"10.1016","volume":"92","author":[{"given":"Alexandra","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisie","family":"Martland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Efficace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sebag-Montefiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Velikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2015.02.021_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1470-2045(12)70116-X","article-title":"Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: A randomised, multicentre, non-inferiority, phase 3 trial","volume":"13","author":"Hofheinz","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jnci\/88.15.1039","article-title":"A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer","volume":"88","author":"Gelber","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1470-2045(07)70144-4","article-title":"TAME: Development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group","volume":"8","author":"Trotti","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","article-title":"Quantitative analyses of normal tissue effects in the clinic (QUANTEC): An introduction to the scientific issues","volume":"76","author":"Bentzen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/00365521.2010.545832","article-title":"\u201cPelvic radiation disease\u201d: New understanding and new solutions for a new disease in the era of cancer survivorship","volume":"46","author":"Andreyev","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib7","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ijrobp.2007.04.054","article-title":"Improving the capture of adverse event data in clinical trials: The role of the International Atomic Energy Agency","volume":"69","author":"Davidson","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib8","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/jnci\/djp386","article-title":"Adverse symptom event reporting by patients vs clinicians: Relationships with clinical outcomes","volume":"101","author":"Basch","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib9","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","article-title":"Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: Results of a questionnaire-based study","volume":"7","author":"Basch","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib10","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1200\/JCO.2010.32.3683","article-title":"Health-related quality of life in non-small-cell lung cancer: An update of a systematic review on methodologic issues in randomized controlled trials","volume":"29","author":"Claassens","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.eururo.2013.10.017","article-title":"Patient-reported outcomes in randomised controlled trials of prostate cancer: Methodological quality and impact on clinical decision making","volume":"66","author":"Efficace","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1470-2045(02)00876-8","article-title":"Quality of life in patients undergoing systemic therapy for advanced breast cancer","volume":"3","author":"Bottomley","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials: The CONSORT PRO extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib14","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s11136-012-0252-1","article-title":"Patient-reported outcomes in randomized clinical trials: Development of ISOQOL reporting standards","volume":"22","author":"Brundage","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib15","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1245\/s10434-012-2827-z","article-title":"Effect of preoperative radio(chemo)therapy on long-term functional outcome in rectal cancer patients: A systematic review and meta-analysis","volume":"20","author":"Loos","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/02841860701348670","article-title":"Late adverse effects of radiation therapy for rectal cancer\u2014a systematic overview","volume":"46","author":"Birgisson","year":"2007","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib17","first-page":"CD006041","article-title":"Preoperative chemoradiation versus radiation alone for stage II and II resectable rectal cancer","volume":"2","author":"De Caluwe","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib18","first-page":"CD008368","article-title":"Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer","volume":"12","author":"McCarthy","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib19","first-page":"CD002102","article-title":"Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma","author":"Wong","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib20","series-title":"Systematic Review: CRD\u2019s Guidance for Undertaking Reviews in Healthcare","year":"2009"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib21","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib22","series-title":"Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims","year":"2009"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib23","series-title":"Basic Clincial Radiobiology","article-title":"Pathogenesis of normal-tissue side-effects","author":"Dorr","year":"2009"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib24","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.ijrobp.2009.08.074","article-title":"The lessons of quantec: Recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome","volume":"76","author":"Jackson","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib25","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib26","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/bjs.5525","article-title":"Late adverse effects of short-course preoperative radiotherapy in rectal cancer","volume":"93","author":"Pollack","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10350-005-0296-1","article-title":"Long-term effect of preoperative radiation therapy on anorectal function","volume":"49","author":"Pollack","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF02235256","article-title":"Preoperative irradiation affects functional results after surgery for rectal cancer: Results from a randomized study","volume":"41","author":"Dahlberg","year":"1998","journal-title":"Dis Colon Rectom"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib29","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer [erratum appears in N Engl J Med 2007 Aug 16;357(7):728]","volume":"355","author":"Bosset","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.canrad.2010.06.017","article-title":"Long-term quality of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial","volume":"14","author":"Tiv","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib31","first-page":"233","article-title":"Locally advanced rectal carcinoma: Preoperative radiotherapy versus postoperative chemoradiation, 10-year follow-up results of a randomized clinical study","volume":"18","author":"Taher","year":"2006","journal-title":"J Egypt Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib32","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib33","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ijrobp.2010.07.007","article-title":"Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: Results from a randomized phase III study","volume":"81","author":"Braendengen","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ejca.2011.06.035","article-title":"Health-related quality of life (HRQOL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III study","volume":"48","author":"Braendengen","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib35","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1200\/JCO.2005.05.256","article-title":"Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: Report of a multicenter randomized trial","volume":"23","author":"Marijnen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib36","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2005.14.779","article-title":"Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: Increased bowel dysfunction in irradiated patients\u2014a Dutch Colorectal Cancer Group study","volume":"23","author":"Peeters","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib37","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/bjs.5819","article-title":"Risk factors for faecal incontinence after rectal cancer treatment","volume":"94","author":"Lange","year":"2007","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib38","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/bjs.6126","article-title":"Urinary dysfunction after rectal cancer treatment is mainly caused by surgery","volume":"95","author":"Lange","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib39","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ejca.2008.12.014","article-title":"Risk factors for sexual dysfunction after rectal cancer treatment","volume":"45","author":"Lange","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib40","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1200\/JCO.2009.26.5264","article-title":"Impact of short-course preoperative radiotherapy for rectal cancer on patients' quality of life: Data from the Medical Research Council CR07\/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial","volume":"28","author":"Stephens","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib41","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"Bujko","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2007.07.007","article-title":"Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: Report of a randomised trial","volume":"84","author":"Pietrzak","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib43","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1200\/JCO.2005.03.6095","article-title":"Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group trial 0012","volume":"24","author":"Mohiuddin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib44","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","volume":"30","author":"Ngan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib45","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1002\/cncr.25943","article-title":"Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer","volume":"117","author":"Park","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib46","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1200\/JCO.2012.42.8771","article-title":"Clinical outcome of the ACCORD 12\/0405 PRODIGE 2 randomized trial in rectal cancer","volume":"30","author":"Gerard","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG c016): A multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib48","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib49","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2003.12.121","article-title":"Beyond the development of health-related quality-of-life (HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer clinical trials\u2014does HRQOL evaluation in prostate cancer research inform clinical decision making?","volume":"21","author":"Efficace","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib50","first-page":"CD003750","article-title":"Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy","author":"Denton","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib51","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2013.07.011","article-title":"STROGAR - Strengthening the Reporting of Genetic Association studies in Radiogenomics","volume":"110","author":"Kerns","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib53","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1200\/JCO.2007.13.3330","article-title":"Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials?","volume":"25","author":"Bruner","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib54","unstructured":"Mapi Research Trust. PROQOLID - Patient-Reported Outcomes and Quality of Life Instruments Database. Available at: http:\/\/www.proqolid.org\/. Accessed July 29,\u00a02014."},{"key":"10.1016\/j.ijrobp.2015.02.021_bib55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1477-7525-11-210","article-title":"The case for an international patient-reported outcomes measurement information system (PROMIS\u00ae) initiative","volume":"11","author":"Alonso","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.prro.2013.07.014","article-title":"Can electronic web-based technology improve quality of life data collection? Analysis of Radiation Therapy Oncology Group 0828","volume":"4","author":"Movsas","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib57","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1200\/JOP.2013.001067","article-title":"Review of electronic patient-reported outcomes systems used in cancer clinical care","volume":"10","author":"Jensen","year":"2014","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib59","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.2012.47.6804","article-title":"Feasibility of long-term patient self-reporting of toxicities from home via the internet during routine chemotherapy","volume":"31","author":"Judson","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib60","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/(SICI)1097-0258(19980315\/15)17:5\/7<697::AID-SIM815>3.0.CO;2-Y","article-title":"Incomplete quality of life data in randomized trials: Missing forms","volume":"17","author":"Curran","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib61","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/(SICI)1097-0258(19980315\/15)17:5\/7<653::AID-SIM812>3.0.CO;2-M","article-title":"Statistical analysis of quality of life with missing data in cancer clinical trials","volume":"17","author":"Troxel","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2015.02.021_bib62","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.ejca.2014.06.020","article-title":"Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: Report of a multicenter randomised trial","volume":"50","author":"Wiltink","year":"2014","journal-title":"Eur J Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615001996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615001996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:54:42Z","timestamp":1566780882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301615001996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0360301615001996"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.02.021","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}